Alebund Pharmaceuticals-B (09637.HK) intends to repurchase up to HK$100 million of H shares.

Zhitong Finance APP News, Alebund Pharmaceuticals-B (09637.HK) announced that the board of directors has resolved to repurchase the company's H shares from time to time in the open market of The Stock Exchange of Hong Kong Limited, pursuant to the general mandate approved by and granted to the company's directors by the company's shareholders at the extraordinary general meeting held on August 14, 2026, for an aggregate amount not exceeding HK$100 million (including transaction costs such as brokerage commissions and stamp duty).